PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Synaptive Medical Inc.

USPTO PatentsView assignee record — 141 granted patents across 39 technology areas, active 2020–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

Explore the portfolio See the ranking
141
Total patents granted
39
CPC technology areas
16.8
Avg claims per patent
—
5-year filing velocity

The verdict

Synaptive holds 141 US patents across 39 technology areas — rank #2,748 of 50,000 tracked assignees.

#2,748
of 50,000 US assignees by volume
Top 2%
by Innovation Score (62.3/100)
16.8
avg claims per patent

Portfolio overview

Synaptive Medical Inc. has been granted 141 US utility patents between 2020 and 2025, placing Synaptive Medical Inc. at rank #2,748 across all assignees tracked by PlainPatent. This portfolio spans 39 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.8 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a Foreign Corporation, Synaptive Medical Inc. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 62.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Historical data spans 2020 through 2025, with 141 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Synaptive Medical Inc.'s 16.8 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 39 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Synaptive Medical Inc. against peers pursuing similar technology classes.

How does Synaptive compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Synaptive holds 141 patents — placing it at rank #2,748 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

Synaptive's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

62 Top 2% higher than 98% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). Below this entry. 60–70: 1,537 US assignees (3%). This entry sits in this band. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView — PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

-1001020304050 202020212022202320242025 2
USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table
Synaptive Medical Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2020 1 0.7%
2021 46 32.6%
2022 35 24.8%
2023 44 31.2%
2024 13 9.2%
2025 2 1.4%

Which technologies does Synaptive Medical Inc. patent most?

Top 15 of 39 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard

Where it ranks

Overall rank by patents

#2,748

Across all tracked assignees

Innovation Score

62.3 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Synaptive Medical Inc. hold?
Synaptive Medical Inc. holds 141 US granted patents filed between 2020 and 2025, spanning 39 technology areas.
What is Synaptive Medical Inc.'s Innovation Score?
Synaptive Medical Inc. has an Innovation Score of 62.3 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Synaptive Medical Inc. focus on?
Synaptive Medical Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 101 patents. The company has filed patents in 39 CPC subclasses total.
Is Synaptive Medical Inc.'s patent filing rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for Synaptive Medical Inc..
What does claim depth mean for Synaptive Medical Inc.'s patents?
Synaptive Medical Inc.'s patents average 16.8 claims each. This falls within the standard range, providing solid legal coverage.
How is the Synaptive Medical Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

How Innovation Score Works

Understand the four dimensions behind the composite score
How to Read Patent Data

Plain-English guide to CPC codes, claims, and metrics
Patent Moat Analysis

How companies use patents as competitive barriers

Explore the patent dataset

A61B technology

Synaptive Medical Inc.'s primary CPC class — all holders and yearly trends
Top 50 patent holders

See where Synaptive Medical Inc. ranks among the largest US patent assignees
All technology classes

Browse every CPC technology area by patent activity
How the score works

The four dimensions behind the Innovation Score

Related

All companies → | All technologies → | Rankings →
Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology — how this data is sourced, computed, and verified.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope